Alka Chaubey
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alka Chaubey
Bionano Genomics, Inc. reported in an 8-K filed June 5, 2026 that Alka Chaubey resigned as Chief Medical Officer, effective July 5, 2026. The proxy statement of Bionano Genomics, Inc. reports total compensation of $756,329 for Alka Chaubey in fiscal 2025, including a base salary of $460,000. Disclosed compensation is on record for 4 fiscal years.
“On June 2, 2026, Alka Chaubey, Ph.D. resigned as Chief Medical Officer of Bionano Genomics, Inc. (the "Company") effective July 5, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Bionano Genomics, Inc. (BNGO)
Proxy statement
Start not stated–2026-07-05
-
Bionano Genomics, Inc. (BNGO)
Proxy statement
Start not stated–2026-07-05
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Bionano Genomics, Inc. (BNGO) | Ph.D., FACMG Chief Medical Officer | $460,000 | $756,329 |
| 2024 | Bionano Genomics, Inc. (BNGO) | Ph.D., FACMG Chief Medical Officer | $459,615 | $661,908 |
| 2023 | Bionano Genomics, Inc. (BNGO) | Ph.D., FACMG Chief Medical Officer | $439,231 | $864,780 |
| 2022 | Bionano Genomics, Inc. (BNGO) | Ph.D., FACMG Chief Medical Officer | $399,269 | $1,317,829 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.